Please login to the form below

Not currently logged in
Email:
Password:

Acorda appoints new CFO

Michael Rodgers replaces David Lawrence who becomes chief business officer

Acorda has reshuffled its senior business leadership, with Michael Rodgers appointed chief financial officer replacing David Lawrence who becomes chief business officer.

Rodgers joins from BG Medicine where he also served as chief financial officer. During his time at BG he led the company's initial public offering and helped launch its first product.

His previous roles include chief financial officer of Indevus Pharmaceuticals, where he stayed for 10 years before the company was acquired by Endo Pharmaceuticals.

Rodgers' predecessor as Acorda's chief financial officer David Lawrence moves to the newly-created role of chief business officer, where he will be responsible for the company's technical operations, project management, IT and facilities.

“We've grown rapidly over the past several years, and our internal operations need to keep pace with the demands of the business,” said Lawrence.

“I'm excited to take on this new challenge at Acorda, overseeing and optimising development of our business operations and infrastructure.”

This growth is led by six therapies in clinical studies that address a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic pain and heart failure. 

9th October 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics